PT  - JOURNAL ARTICLE
AU  - Lopez Garcia, B
AU  - Ortonobes Roig, S
AU  - Echeverria Esnal, D
AU  - Retamero Delgado, A
AU  - Luque Pardos, S
AU  - Ferrandez Quirante, O
AU  - Comin Colet, J
AU  - Salas Sanchez, E
TI  - DI-052 Chronic heart failure patients’ knowledge of their medicines; a system for post-discharge pharmacist-led educational interventions
AID  - 10.1136/ejhpharm-2013-000436.223
DP  - 2014 Mar 01
TA  - European Journal of Hospital Pharmacy: Science and Practice
PG  - A91--A91
VI  - 21
IP  - Suppl 1
4099  - http://ejhp.bmj.com/content/21/Suppl_1/A91.1.short
4100  - http://ejhp.bmj.com/content/21/Suppl_1/A91.1.full
SO  - Eur J Hosp Pharm2014 Mar 01; 21
AB  - Background Patients with chronic heart failure (CHF) have complex medicines regimens which can frequently be difficult to remember/understand, especially for elderly patients. This fact can be responsible for non-adherence and drug related problems (DRPs) in this population. In our hospital, a post-discharge pharmacist educational interventions system (PEI) has been implemented as a part of a multidisciplinary CHF disease management system with two different modalities of care: telemonitoring or usual care. Purpose To describe patients’ knowledge of the pharmacological treatment for CHF when included in this PEI by using a quantitative scale and to seek a relationship between the degree of knowledge and the CHF patient’s characteristics and the modality of care. Materials and methods Retrospective observational study including all CHF patients attending our PEI from May 2010–2013. Data collected: demographics; New York Heart Association (NYHA) class, modality of care that had been received: telemonitoring (TM) vs. usual care (UC); total no. of drugs (TD); degree of knowledge, no. of comorbidities (NC); self-administration of medicines (SA); self-reported adherence to diet (AD); self-reported adherence to medicines (AM); contraindicated drugs (CID) and DRP. The quantitative knowledge scale calculated the% of their CHF medicines of which the patients knew the dose, frequency and indication (DFI). A good knowledge was considered when a patient knew ≥50% DFI of all their CHF drugs. Statistical test: Chi-Square and Fischer exact test for dichotomous variables and t-test and U-Mann Whitney test for continuous responses. Results Patients: 185 Patient profile: 108 (58.4%) male; mean age: 73.08 (SD 0.839) years; patients/NYHA class 145 (79.2%)/class 1–2, 38 (20.7%)/class 3–4; usual care 139 (75.1%), telemonitoring 46 (24.9%); TD: 8.53 (SD 0.244); NC 3.53 (SD 0.135). Adherence and knowledge. SA: 113 (61.1%); AD: 153 (82.7%); AM: 179 (96.8); knowledge of CFH medicines, mean% drugs with knowledge of DFI: 39.08 (SD 2.694). DRPs: 40 patients (21.6%). Comparison between patients with a good and a poor knowledge: age 71.16 years vs. age 74.6 (p = 0.05); NC: 3.26 vs. 3.74 (p = 0.075); telemonitoring care 27/70 (38.6%) vs. 11/88 (12.5%) (p < 0.001); SA 56/70 (80%) vs. 49/88 (55.7%) (p = 0.001). No other significant differences were observed between the two groups. Conclusions The post-discharge PEI system allowed us to check the degree of knowledge in our CHF patients and also DRPs in almost 25% of them. Older age and a tendency to a more treatment complexity observed in a higher number of comorbidities were the only factors related to a poorer knowledge of the medicines. Telemonitoring as a modality of care increased the knowledge of medicines in these patients and their self-care allowing them to take the medicines by themselves. The use of telemonitoring in our PEI would probably increase patients’ knowledge of their medicines and reduce DRPs. No conflict of interest.